Target intelligence / Profile preview

Fatty acid degradation pathway

Molecular classification
Other (metabolic pathway), includes numerous enzymes (e.g., enzyme, transporter, receptor for individual components)
01

Overview

The **fatty acid degradation pathway** (also called fatty acid β-oxidation or fatty acid oxidation, FAO) is a highly conserved metabolic process whereby fatty acids—after activation by conversion to acyl-CoA—are transported into mitochondria or peroxisomes and sequentially degraded through cycles of oxidation, hydration, and cleavage to produce acetyl-CoA, NADH, and FADH₂, which feed into the TCA cycle and the electron transport chain to generate ATP[1][2][3][4][5][8]. Major steps include lipolysis, fatty acid activation, mitochondrial or peroxisomal import, and β-oxidation cycles[1][3][5][8]. Dysregulation of the pathway or inherited enzyme deficiencies can cause energy metabolism disorders and contribute to pathologies including cancer, heart disease, and immunological dysfunction[2][4].

Other names
Fatty acid β-oxidationfatty acid oxidationFAObeta-oxidation pathway
02

Mechanism of action

Not applicable at the pathway level. For enzyme inhibitors, e.g., CPT1 inhibition reduces β-oxidation and lowers ATP production from fatty acid catabolism[2].

03

Biological functions

Energy productionMetabolic homeostasisCatabolism of fatty acidsRegulation of immune function
04

Disease associations

Cancer (altered fatty acid oxidation in tumors)Cardiovascular diseaseInherited metabolic disorders (e.g., FAO deficiencies)Other (immune dysfunction, metabolic syndrome)
05

Safety considerations

Not applicable at the pathway level.For enzyme inhibitors (e.g., CPT1 inhibitors), risks include hypoglycemia, hepatic steatosis, and energy metabolism perturbation[2].
06

Biomarkers

Indirect: Acylcarnitines and acyl-CoA derivatives are clinical biomarkers for inborn errors of FAO[7]these are associated with specific enzyme deficiencies, not the entire pathway.

Beyond the preview

Go deeper on Fatty acid degradation pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fatty acid degradation pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call